Spilling the RT
Spilling the RT
Podcast Description
Spilling the RT is a podcast series from Elekta that features conversations around radiation therapy with clinical experts who are changing the game in radiation oncology. Each episode explores exciting research, technology or emerging trends with leaders who are not just advancing the field, but passionate about making a difference. Plus, we get personal – discovering what drives these individuals and how their journeys began.
Hosted and moderated by Elekta’s Global Clinical Communications Manager, Emily Basset, this series is your front-row seat to everything radiotherapy. Subscribe to Spilling the RT on Apple and Spotify or listen on Elekta’s YouTube channel.
Podcast Insights
Content Themes
The podcast covers a variety of topics centered on advancements in radiation therapy, with episodes focusing on emerging technologies, groundbreaking research, and trends in oncology. For example, an episode featuring Dr. Alison Tree discusses the innovative treatment approaches for prostate cancer and emphasizes the need for improved patient experiences through fewer hospital visits and higher doses in therapy.
Spilling the RT is a podcast series from Elekta that features conversations around radiation therapy with clinical experts who are changing the game in radiation oncology. Each episode explores exciting research, technology or emerging trends with leaders who are not just advancing the field, but passionate about making a difference. Plus, we get personal – discovering what drives these individuals and how their journeys began.
Hosted and moderated by Elekta’s Global Clinical Communications Manager, Emily Basset, this series is your front-row seat to everything radiotherapy. Subscribe to Spilling the RT on Apple and Spotify or listen on Elekta’s YouTube channel.
Patients with rectal cancer often need a permanent colostomy or suffer from LARS syndrome, both of which can significantly reduce quality of life. At University Hospital Tübingen, radiation oncologist Prof. Dr. med. Cihan Ganiand his team are working to change that with the MARS (MR Adaptive Dose-Escalated Radiotherapy for Rectal Sparing) trial, where they are using Elekta Unity MR-Linac to deliver a precise high-dose boost alongside conventional chemoradiation to increase clinical complete response rates and help more patients avoid surgery.
Tune in to hear Prof. Gani talk about his own journey from first hearing about MR-guided radiotherapy (MRgRT) to now leading the MARS trial, where he’s using MR-adaptive dose-escalated radiation therapy to redefine care for rectal cancer.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.